Medical News

RSS

Sensible Nutrition selected as Fitcorp's new nutrition partner

Fitcorp has selected Sensible Nutrition as their new nutrition partner. Fitcorp understands that nutrition is a major component of fitness and health and wants their members to have the ability to meet with Sensible Nutrition’s nationally renowned registered dietitians (RDs).

13 Nov 2009

MSU team looks for characteristics of virtual workout partners to help improve physical fitness

Based on evidence people work harder with a partner than when working alone, a team of Michigan State University researchers are pairing college-age students with a virtual workout partner to study the impact on exercise trends.

13 Nov 2009

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

The U.S. Food and Drug Administration has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

13 Nov 2009

CRPS patients fare better with aggressive physiotherapy treatment, says new study

The saying "more pain, more gain" may be true for those already in terrible pain due to a chronic and debilitating condition, contrary to received wisdom. For those with Type I Complex Regional Pain Syndrome (CRPS), working through the pain of an aggressive physiotherapy program often leads to far better results than a more cautious pain-free approach.

13 Nov 2009

Adult smoking declines have stopped, says government report

The government's report today that adult smoking declines have stalled since 2004 is an urgent warning to elected officials that it is premature to declare victory over tobacco and much more must be done to continue reducing tobacco use, which remains the number one preventable cause of death in the United States.

13 Nov 2009

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

13 Nov 2009

Key components of health care reform slow down the growth of health care costs, shows report

A new report released today by Business Roundtable, an association of chief executive officers of leading U.S. companies, shows that key components of health care reform could slow the growth of health care costs and offer real savings for companies and their employees.

13 Nov 2009

PDL BioPharma to pay $200 million special dividend payment to stockholders

PDL BioPharma, Inc. (PDL) today announced that it will pay a $200 million special dividend to stockholders, with part of the proceeds from the $300 million securitization transaction completed on November 2, 2009.

13 Nov 2009

Nonprofit organizations receive a total of $4.6 million in grants from Edwards Lifesciences Fund

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that The Edwards Lifesciences Fund is granting $1.8 million to 107 nonprofit organizations as part of its fifth annual grant cycle. This fund is a donor-advised fund of the Vanguard Charitable Endowment Program.

13 Nov 2009

BioInvent International, Daiichi Sankyo sign licence and discovery agreement

BioInvent International AB has announced that it has entered into a licence and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.

13 Nov 2009

Alcohol and drug treatment facility receives Joint Commission accreditation

The Right Step, one of the most respected and affordable alcohol and drug treatment facilities in the country, is proud to announce its recent accreditation by The Joint Commission (JCAHO).

13 Nov 2009

New gene therapy may breach the armor of cancerous tumors

The seeming invincibility of cancerous tumors may be crumbling, thanks to a promising new gene therapy that eliminates the ability of certain cells to repair themselves. Researchers at the Cornell University College of Veterinary Medicine have discovered that inactivation of a DNA repair gene called Hus1 efficiently kills cells lacking p53 -- a gene mutated in the majority of human cancers.

13 Nov 2009

Health-related and psychosocial characteristics are associated with elder self-neglect

Seniors who neglect themselves, risking their own health and safety, tend to be individuals with limited social networks and little social engagement, according to a study by Rush University Medical Center.

13 Nov 2009

University of Colorado Hospital signs contract to implement Lawson enterprise applications

Lawson Software today announced that the University of Colorado Hospital signed a contract to implement multiple Lawson enterprise applications to help enhance its human resources operations and improve overall business processes. An existing Lawson customer, the hospital is adding Lawson Global Human Resources, Talent Acquisition, Absence Management and Employee & Manager Self Service applications.

13 Nov 2009

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in Phase I clinical trial development that targets NGF for the treatment of chronic pain.

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

New minimally invasive laser treatment saves the lives of twins with TTTS

As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.

13 Nov 2009

Masked hypertension in CKD children can increase risk of heart disease

Many children with chronic kidney disease (CKD) who show normal blood pressure readings at the doctor's office have high blood pressure when tested at home, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

13 Nov 2009

Innomed/BioRobotics to be Health Robotics' exclusive strategic partner in Korea

Health Robotics today announced that Innomed/BioRobotics, on the heels of its prior market success with Oncology Surgery robots, has exclusively selected Health Robotics' CytoCare(TM) Robot to reach its objective to become the gold standard for Oncology Robotics IV Admixtures in the Republic of Korea and synergistically provide an end-to-end Cancer Robotics solution.

13 Nov 2009

Peplin merges with LEO Pharma

Peplin, Inc. today announced that it has completed its merger with LEO Pharma A/S (LEO) after obtaining the approval of the majority of Peplin stockholders. The deal was originally announced on 3 September, 2009 when LEO, a privately-held, leading global pharmaceutical company within Dermatology and Critical Care, agreed to acquire all outstanding securities of Peplin for approximately US$287.5 million in cash. The merger consideration will be distributed to holders of common stock and CDIs promptly.

13 Nov 2009

Medical News

Sensible Nutrition selected as Fitcorp's new nutrition partner

MSU team looks for characteristics of virtual workout partners to help improve physical fitness

CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older

CRPS patients fare better with aggressive physiotherapy treatment, says new study

Adult smoking declines have stopped, says government report

Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process

Key components of health care reform slow down the growth of health care costs, shows report

PDL BioPharma to pay $200 million special dividend payment to stockholders

Nonprofit organizations receive a total of $4.6 million in grants from Edwards Lifesciences Fund

BioInvent International, Daiichi Sankyo sign licence and discovery agreement

Alcohol and drug treatment facility receives Joint Commission accreditation

New gene therapy may breach the armor of cancerous tumors

Health-related and psychosocial characteristics are associated with elder self-neglect

University of Colorado Hospital signs contract to implement Lawson enterprise applications

Abbott signs agreement to acquire global rights to PanGenetics BV's PG110

New and effective medicines underway for treating a wide range of diseases affecting women

New minimally invasive laser treatment saves the lives of twins with TTTS

Masked hypertension in CKD children can increase risk of heart disease

Innomed/BioRobotics to be Health Robotics' exclusive strategic partner in Korea

Peplin merges with LEO Pharma

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News